Impact of Antiplatelet and Anticoagulant Therapies on Platelet-related Prognostic Markers in Patients With Esophageal Cancer

Conclusion: Researching detailed antiplatelet and anticoagulant therapies could reinforce the prognostic value of platelet-related prognostic markers in ESCC.

Source: In Vivo - June 29, 2020 Category: Research Authors: ISHIBASHI, Y., TSUJIMOTO, H., KOUZU, K., ITAZAKI, Y., TSUCHIYA, S., FUJISHIMA, S., YAGUCHI, Y., SUGASAWA, H., NOMURA, S., ITO, N., HARADA, M., NAGATA, H., SHINTO, E., KISHI, Y., UENO, H. Tags: Clinical Studies Source Type: research